Enjoying this bite?
Sign in (free) to track this channel, unlock new bites the moment they drop, and search every summary we've ever made.
Source: YouTube. Summary is AI-generated from the video's captions and may contain errors. It does not represent the views of TubeBite, the creator, or YouTube. Watch the original before relying on anything important.
SUMMARY
Parkev Tatevosian, CFA, examines IBM's recent financial performance, highlighting accelerated revenue growth and improved operating margins despite a significant stock price decline in 2026. The analysis weighs the company's attractive valuation against risks posed by artificial intelligence competition and forecasts a favorable long-term outlook.
MAIN POINTS
- IBM stock declined 25% in 2026, mainly due to a software sector sell-off and AI-related competitive threats.
- IBM's revenue growth accelerated from 1.4% in 2024 to 9.7% on a trailing 12-month basis, surpassing expectations for a mature company.
- Operating profit margins improved to 18.2% in 2025, the highest in over a decade, while cash flow to sales ratios remained volatile.
- IBM's service-oriented model limits working capital needs, and internal use of AI is expected to boost efficiency and margins.
- The stock trades at a forward P/E of 17.4, near multi-year lows, and updated intrinsic value estimates point to significant upside.
- Despite heightened risks from AI competition, the fair value estimate of $325 remains well above the current price, supporting a buy recommendation as of May 18th.
DETAILED ANALYSIS
IBM has experienced a notable stock price decline of 25% in 2026, largely attributed to sector-wide concerns following announcements from AI competitors such as Anthropic. This downturn occurred despite the company achieving its strongest revenue growth in years, with rates rising from 1.4% in 2024 to 7.6% in 2025, and further to 9.7% over the trailing twelve months. For a company of IBM’s size and maturity, this near double-digit growth is exceptional and exceeds typical investor expectations.
Wall Street analysts forecast continued mid-single-digit revenue growth through 2028, projecting revenue to climb from $67.5 billion to $79 billion.
Operating margins have also shown significant improvement, rebounding from a low of 3.9% in 2022 to 18.2% in 2025, the highest level in over a decade. This margin expansion, coupled with the company’s relatively stable cash flow to sales ratio—currently at 19.5%—suggests operational resilience. IBM’s business model, focused on services rather than asset-heavy investments, means that revenue growth does not require substantial increases in working capital.
Additionally, the company is leveraging artificial intelligence internally to enhance efficiency, aiming to grow revenue while maintaining or even reducing headcount.
Valuation metrics further strengthen the investment case. IBM is trading at a forward price-to-earnings ratio of 17.4, close to its lowest levels since early 2024, making it relatively inexpensive compared to historical norms. Updated intrinsic value calculations, which factor in higher free cash flow expectations, yield a fair value estimate of $325 per share—well above the current market price of $223.
However, the risk profile has shifted. The potential impact of AI-driven competition has widened the range of possible outcomes, introducing greater uncertainty to future cash flows. Despite this, the expected value remains attractive, and the analysis concludes with a reaffirmed buy recommendation as of May 18th, reflecting both the company’s operational improvements and its discounted valuation.
LINKS
- YouTube channel membership for exclusive perks and early access.
- Special offer for The Motley Fool Stock Advisor.
- Parkev Tatevosian's book on a six-step investing framework.
- Fiscal.ai investment research platform with a discount for viewers.
- Webull investing platform with bonus shares for new sign-ups.
- Subscribe to Parkev Tatevosian's free monthly Substack newsletter.